Amedica reported lower total product revenue for the second quarter, down 18 percent as compared to the same period last year.
The Latest
Spine Pain Management reported its second quarter financial results.
Bone Biologics named Stephen R. La Neve CEO and President.
Zyga received FDA clearance for the SImmetry System for either two-incision or single-incision techniques.
InVivo Therapeutics' CEO Mark Perrin was featured on the Fox Business Network program "Mornings with Maria."
SeaSpine reported $33.5 million in revenue for the second quarter of 2015, a 6 percent decrease over the same period last year.
A new study published in Spine examines how hospital characteristics impact Medicare charges and payments for cervical spine surgery.
Here are 10 things for spinal surgeons to know for August 13, 2015.
Individualizing data collectionAs the healthcare industry continues to shift towards a patient-centric structure, treatment must tailor to the individual, not the masses.
A new study published in Spine examined examines whether the deformity angulation ratio can assess neurologic risks in patients undergoing surgical correction for spinal deformity.